GLP-1 provider comparison · 52 recorded providers

Find your cheapest GLP-1 program

Brand Ozempic's list price is $1,028/mo. Compounded semaglutide, which is not FDA-approved, starts at $49/mo on a 12-month plan. Compare 52 programs by real price and what's included.

See Embody from $49/mo, 12-month plan

Paid link: we may earn a commission. Prices recorded Nov 6, 2026.

Compounded drugs are not FDA-approved. FDA source.

En español

Published plan prices

Compare plan terms
See all 52 provider records →

Amounts are recorded medication and program subtotals for the selected molecule. Other required fees, dose changes and renewal terms need confirmation. For brand-specific prices, see each seller.

In our published order

Partner programs

See all 52

Embody

Compounded

Semaglutide

$49/mo

12-month plan, $79/mo monthly

Tirzepatide

$99/mo

12-month plan, $129/mo monthly

  • Recorded as available in 48 states
  • Consultation on record: included

TrimRx

Compounded

Semaglutide

From $179

seller says GLP-1, term not stated

Tirzepatide

From $279

seller says GLP-1 + GIP, term not stated

  • Recorded as available in 45 states
  • Consultation on record: free

SnagRx

Compounded

Semaglutide

$59/mo

sale price, term not stated

Tirzepatide

$109/mo

sale price, term not stated

  • Recorded as available in 48 states
  • Consultation on record: included

Paid links. Placement follows our published order. It is not a score or an award. Embody: $49/mo semaglutide, $99/mo tirzepatide on a 12-month plan; $79/mo semaglutide, $129/mo tirzepatide on a monthly or one-month plan, recorded Nov 6, 2026. Prepaid plans differ.

By route

What each costs

Understand a quoted monthly price

Recorded one-month medication and program subtotals start at $79/month in the current dataset. Required labs, dose changes, consultation or shipping may be unconfirmed. Introductory discounts and prepaid monthly equivalents are separate from a monthly-plan price.

Latest dated individual provider record: Nov 11, 2026. This is a partial record date, not a verification of every provider or today's checkout. Price-only checks have their own dates.

Every program

Compare 52 recorded providers

Recorded medication and program subtotals are not verified all-in costs. Labs, dose changes and other fees may be unknown. See pharmacy, clinician and cancellation evidence.

52 of 52 records, in our provider order

Recorded prices by provider, with a paid link per row. Unknown costs are not free.
ProgramPrice
Embody

Semaglutide, 12-month plan, $79/mo monthly · Tirzepatide $99/mo

$49/moVisit site
TrimRx

Semaglutide, seller says GLP-1, term not stated · Tirzepatide From $279

From $179Visit site
Oak Longevity

Semaglutide, 12-month plan · Tirzepatide From $185/mo

From $119/moVisit site
Gala Health

Semaglutide, drug and term not stated · Tirzepatide From $69/mo

From $69/moVisit site
MEDVi

Semaglutide, monthly plan

$199/moVisit site
SkinnyRx

Semaglutide, first month, renewal not published · Tirzepatide $99

$99Visit site

Compounded medications are not FDA-approved. FDA guidance. Insurance acceptance is not a promise of drug coverage. For Medicare eligibility and terms, see CMS's GLP-1 Bridge information.

Open the full decision table with evidence and unknown costs

Before you pay

What to check before you buy

  1. 1

    Get the complete bill

    Ask for the amount due today and at renewal, required services, dose pricing and the total commitment.

  2. 2

    Check the clinical team

    Identify your prescriber and dispensing pharmacy, and verify the relevant state licenses before treatment.

  3. 3

    Read the written terms

    Cancellation, refunds, recurring billing and prepaid commitments can differ even when the headline price looks similar.

Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness or quality before marketing. FDA recommends a prescription and a state-licensed pharmacy. FDA source and patient recommendations.

Find programs to compare

A few questions about your budget, insurance and medication, then programs to compare.

Start the quiz

Partner programs by what you need

Paid links. Each is the first partner in our published order that matches. The order is not a score.

Looking for semaglutide

$79/mo semaglutide, monthly plan

On the record, this fits readers looking for compounded medication who are paying without insurance.

Looking for tirzepatide

$129/mo tirzepatide, monthly plan

On the record, this fits readers looking for compounded medication who are paying without insurance.

Want to use insurance

$158/mo, monthly plan

On the record, this fits readers looking for compounded medication who want to use insurance.

Medicare, since July 1, 2026

Medicare covers some GLP-1s at $50 a month

The Medicare GLP-1 Bridge covers Foundayo (tablet), Wegovy (injection or tablet) and Zepbound (KwikPen only) for eligible Part D enrollees, through December 31, 2027. BMI rules apply. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible, and neither are people whose drug plan can cover a GLP-1. Medicare.gov.

Medicaid, 13 states in KFF's January 2026 count

See Medicaid coverage in your state

KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.

Free tools, no signup

Play with your numbers

See all tools

Never overpay for your GLP-1 again.

Free Tuesday email with the cheapest programs + price drops.

Latest GLP-1 news

All articles

Explore resources

GLP-1 timeline

Recent events that changed access and price, each linked to its source.

  1. Dec 15, 2025

    NAION lawsuits centralized

    A federal panel created MDL No. 3163 for vision-loss claims.

  2. Mar 9, 2026

    Hims & Hers changes course

    It said it would stop advertising compounded GLP-1s, and Novo Nordisk dismissed its lawsuit.

  3. Apr 1, 2026

    Foundayo approved

    FDA approved orforglipron, a once-daily pill, for weight management.

  4. Apr 21, 2026

    BALANCE not moving ahead in Medicare in 2027

    KFF reports CMS's decision. Medicaid states can still join.

  5. Apr 30, 2026

    503B proposal

    FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list.

  6. Jul 1, 2026

    Medicare GLP-1 Bridge began

    $50 a month for eligible Part D enrollees, through December 31, 2027.

Not sure which program is right for you?

Answer a few questions about your budget, insurance and medication, and see programs to compare.

Take the quiz

EmbodyAd

from $49/mo, 12-month plan

Visit Embody